Shenzhen Weiguang Biologic (002880.SZ) traded flat 0 % during a 24 hours period ending at 04:59 PM Central Europe on Monday 26th. One Shenzhen Weiguang Biologic stock can currently be bought for about CNY 20.04 on popular exchanges. Current supply of Shenzhen Weiguang Biologic stocks is 226.9 mn. Shenzhen Weiguang Biologic has a current market capitalization of CNY 4.5 bn and approximately CNY 36.4 mn worth of Shenzhen Weiguang Biologic was traded on exchanges in the last 24 hours. Since last month end, Shenzhen Weiguang Biologic has traded -8.41 % down. Simple moving average of last 200 days is at CNY 21.43. The highest price of past 52 weeks was recorded at CNY 33.79 on 02/05/2026. 52 weeks low was at CNY 18.57 on 07/27/2026.
Here is how related stocks have performed in the past 24 hours:
Carsgen Therapeutics (2171.HK) traded up 3.6 % and now trades at HKD 11.17. Carsgen Therapeutics has a market capitalisation of HKD 6.3 bn. CARsgen Therapeutics Holdings Limited reported preliminary positive outcomes from its investigator‑initiated trial of the satricabtagene autoleucel (satri‑cel) CAR T‑cell therapy in patients with locally advanced gastric or gastroesophageal junction cancer who had undergone curative surgery. The results, presented as a poster at the European Society for Medical Oncology Congress, highlighted that none of the ten treated patients experienced disease recurrence during follow‑up, with a 12‑month disease‑free survival rate of 100 %. Safety observations showed manageable cytokine release syndrome without severe neurotoxicity. The company noted that the therapy may clear minimal residual disease and emphasized its intent to advance satri‑cel into earlier‑line and perioperative settings, building on its recent approval for advanced gastric cancer in China.
Changzhou Galaxy Century Micro-electronics (688689.SS) traded flat 0 % and now trades at CNY 35.13. Current market capitalisation for Changzhou Galaxy Century Micro-electronics is CNY 5.4 bn. Current price/earnings ratio for Changzhou Galaxy Century Micro-electronics is 41.42.
Hengerda New Materials Fuj (300946.SZ) traded flat 0 % and now trades at CNY 33.01. Hengerda New Materials Fuj has a market capitalisation of CNY 5.4 bn. Current price/earnings ratio for Hengerda New Materials Fuj is 251.75.
Zhuzhou Qianjin Pharmaceut (600479.SS) traded flat 0 % and now trades at CNY 10.84. Zhuzhou Qianjin Pharmaceut has a market capitalisation of CNY 5.4 bn. Current price/earnings ratio for Zhuzhou Qianjin Pharmaceut is 14.67. ZHUZHOU QIANJIN PHARMACEUT announced its dividend plan for the third quarter of 2026, opting for a cash distribution to shareholders. The company will issue dividends on a per‑share basis, reflecting a moderate payout relative to its earnings. While the specific cash amount has not been disclosed in the summary, the move signals the firm’s intent to reward investors amid a broader market trend of higher dividend yields, especially given the current low interest‑rate environment. QIANJIN PHARMACEUT also highlighted ongoing efforts to improve operating efficiency and product commercialization, noting that the impact of pricing negotiations and procurement strategies is expected to ease over time. The dividend decision comes as part of a wider industry pattern, with several peers also unveiling or increasing their payouts during the same quarter.
Chongqing Zhengchuan Pharmaceutical Packaging (603976.SS) traded flat 0 % and now trades at CNY 30.2. Current market capitalisation for Chongqing Zhengchuan Pharmaceutical Packaging is CNY 5.4 bn. Chongqing Zhengchuan Pharmaceutical Packaging has a current price to earnings ratio of 258.92.
About Shenzhen Weiguang Biologic
Shenzhen Weiguang Biological Products Co., Ltd is a health care biotechnology company based in Shenzhen, China. The company specializes in manufacturing special pharmaceuticals, particularly blood products. Shenzhen Weiguang Biological Products serves customers within China. The official website for the company is www.szwg.com and it trades on the Shenzhen Stock Exchange.